Quantum Capital Management (California)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Quantum Capital Management (California)'s BMY Position: Q3 2020 in Review
Quantum Capital Management (California) increased its Bristol-Myers Squibb (BMY) stake by 4.8% in Q3 2020, buying an estimated $1.02K and bringing the position to 373 shares worth $22K. The position accounts for 0.02% of the portfolio, ranked #195.
Quantum Capital Management (California) first reported a position in BMY in Q3 2013 and has held it in 7 quarters since. The position peaked at $76K in Q4 2013. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.
- Quantum Capital Management (California) held 373 shares of Bristol-Myers Squibb worth $22K as of Q3 2020.
- Quantum Capital Management (California) bought 17 Bristol-Myers Squibb shares in Q3 2020, an estimated $1.02K.
- Bristol-Myers Squibb made up 0.02% of Quantum Capital Management (California)'s portfolio in Q3 2020, its #195 holding.
- Quantum Capital Management (California) first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 7 quarters since.
- Quantum Capital Management (California)'s Bristol-Myers Squibb position peaked at $76K in Q4 2013.
- 2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.
Based on Quantum Capital Management (California)'s 13F filing for Q3 2020, filed 16 Nov 2020.